MedTrace Logo

PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED

NCT05142332 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 541

Last updated 2023-12-13

Study results available
· View outcomes & findings →

Summary

The goal of this research is to increase COVID-19 vaccine acceptance and uptake in vulnerable populations whose primary (and often only) health care access occurs in emergency departments (ED Usual Source of Care Patients). Toward this goal, the investigators will conduct one on one interviews and focus groups with ED Usual Source of Care Patients and community partners and produce trusted messaging informational platforms (PROmotion of COvid-19 VA(X)ccination in the Emergency Department - PROCOVAXED) that will address barriers to COVID-19 vaccination, especially vaccine hesitancy. The investigators will then conduct a cluster-randomized, controlled trial of PROCOVAXED platforms in six EDs to determine whether their implementation is associated with greater COVID-19 vaccine acceptance and uptake in ED Usual Source of Care Patients.

Conditions

  • Covid-19 Vaccine
  • Vaccine Hesitancy

Interventions

OTHER

Covid-19 vaccine education materials

videos and flyers containing Covid-19 vaccine educational information

Sponsors & Collaborators

Principal Investigators

  • Robert Rodriguez, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-06
Primary Completion
2022-07-28
Completion
2022-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05142332 on ClinicalTrials.gov